Provider review
MEDVi review
A real price is published, but its own page states two figures for tirzepatide.
MEDVi's own /tirz-166 landing page headlines "$166/mo — Price Locked" and separately states "$199 for Tirzepatide" in its body copy — a same-page contradiction we could not resolve from the page itself.
Transparency scorecard
1 of 4 disclosed openly
What MEDVi discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
MEDVi's own /tirz-166 landing page headlines "$166/mo — Price Locked." The same page's body copy separately reads "$166 for Semaglutide or $199 for Tirzepatide."
What you actually pay, month to month
For semaglutide, the headline and body-copy figures agree: $166/month. For tirzepatide, the body copy states $199/month, distinct from the page's own $166 headline — we treat $199 as the stated tirzepatide figure since the body text names it specifically by drug, but the page's own inconsistency means this could not be independently confirmed as the actual billed amount.
The commitment trap
The tirzepatide headline and body copy on the same page disagree about the price ($166 vs. $199) — not a prepay or auto-refill mechanism, but a same-page contradiction we could not resolve from MEDVi's own materials.
Checked live on MEDVi's own site at https://glp1.medvi.org/tirz-166 in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off MEDVi's own public pages on the date shown, not from a third-party comparison table.
The bottom line
MEDVi, LLC dba MEDVi is a real, live telehealth marketing platform selling compounded tirzepatide and compounded semaglutide as headline, priced products, with compounded sermorelin available only as a post-checkout upsell. Its own site names three partner pharmacies (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding) but states no 503A/503B regulatory category for any of them, and publishes no states-served list. FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455, February 20, 2026) over compounded-drug labeling — the same class of finding several peers on this roster already carry with a knock, not a disqualifying one on its own. An earlier version of MEDVi's marketing was separately reported by outside journalism to have used fabricated physician names in ad creative; a live check of MEDVi's current core site found no such named, invented physicians on the pages checked today.
MEDVi appears on our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want one company selling both compounded tirzepatide and compounded semaglutide, with a headline price for each published directly on its site.
- You're comfortable reading the FDA letter and the fabricated-marketing history yourself and deciding they don't change your view of the company today.
Look elsewhere if
- You want the number on the landing page to be the number you're billed — MEDVi's own /tirz-166 page states two different prices for tirzepatide, and we could not determine from the page which one applies.
- You want a stated pharmacy regulatory category or a published states list — MEDVi discloses neither.
- An open FDA warning letter, or a documented history of fabricated marketing content, is a hard line for you regardless of what has since changed.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what MEDVi bundles in, and what it does not.
Clinician consult
Not itemized with a specific inclusion/exclusion statement on…
the pages checked.
Bloodwork / labs
Not stated on the pages checked.
Follow-ups and dose changes
Not itemized on the pages checked.
Human support
No dietitian, nurse, or structured coaching program is named…
anywhere on the pages checked. Prescribing runs through named clinical networks (OpenLoop Health, CareGLP-affiliated P.C.s) rather than any named individual clinician.
Injection supplies
Not itemized on the pages checked.
Shipping
Not itemized with a specific cost or window on the pages checked
Who fills it, and who's watching
The pharmacy
Three named partner pharmacies appear in MEDVi's own site footer — Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — but neither "503A" nor "503B" appears anywhere on the pages checked. Named pharmacies, no stated regulatory category.
Oversight
Not itemized with a specific inclusion/exclusion statement on the pages checked. Not itemized on the pages checked.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
No states-served list or exclusion list was found anywhere on the pages checked.
The honest cons
The part they would rather you skipped
FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455, February 20, 2026, Center for Drug Evaluation and Research) — the same date, office, and "identifies '[name]' on the pictured label, suggesting [name] is the compounder when in fact it is not" template already documented on this roster for a peer provider, addressed to MEDVi's own registered Delaware corporate address. Separately, outside investigative journalism (Futurism; Drug Discovery Trends) previously reported that MEDVi's advertising used fabricated physician names in ad creative; a live check of MEDVi's current core site (2026-08-03) found no named, invented physicians anywhere on the pages checked today, though this was not an exhaustive sweep of every historical ad. Neither finding disqualifies MEDVi from this roster on its own, per this site's standing rule for an FDA letter, but both are on the record here.
- MEDVi's own /tirz-166 landing page states two different prices for tirzepatide on the same page ($166 headline vs. $199 body copy) — see this review's knock and pricing for the full finding.
- No 503A/503B regulatory category is stated for any of the three named partner pharmacies.
- No states-served list is published anywhere on the site we could find.
- Compounded sermorelin is sold only as a post-checkout upsell, not as a standalone, independently priced product — it does not appear on this site's sermorelin board for that reason.
None of this is unique to MEDVi — the whole category shares it.
How it compares
The providers we rank on our semaglutide provider ranking — the most specific board MEDVi sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- TRTrimiNames two 503A pharmacies directly, undercut by an annual-prepay headline.
- OAOakA flat, no-subscription price — but no pharmacy is named anywhere on the site.
- Strut HealthAn FDA warning letter over labeling, plus an auto-refill price on every product.
- RXRxPepsDirectNo subscription — a per-visit fee, but it can't refund the medication charge.
- PRPreventiveMDShows every price tier in one table — but its own headline is the cheapest one.
- NuBloomFlat, checkable pricing — undercut by its own FAQ and an unfilled legal clause.
- Precision TelemedNames its actual compounding pharmacy directly on its own product pages.
- NexLifeA real price table, undercut by a guarantee that excludes the medication cost.
33 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect MEDVi's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MEDVi's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.